Audrey Thomas‐Schoemann
- Oncology top 5%
- Colorectal Cancer Treatments and Studies 11
- Cancer Treatment and Pharmacology 10
- Cancer Immunotherapy and Biomarkers 8
- HER2/EGFR in Cancer Research 7
- Hematology top 10%
- Internal Medicine top 10%
- Genetics top 10%
-
- Renal cell carcinoma treatment 10
- Lung Cancer Treatments and Mutations 6
-
- Melanoma and MAPK Pathways 6
-
- Cancer Genomics and Diagnostics 5
- Co-authors
- François GoldwasserBenoı̂t BlanchetMichel VidalPascaline Boudou‐RouquetteJérôme AlexandreGaëlle NoéAudrey BellesœurJennifer Arrondeau
- Cited by
- OncologyHematologyInternal Medicine
- Journals
- Journal of Clinical Oncology (5 papers)Cancer Chemotherapy and Pharmacology (4 papers)Annals of Oncology (3 papers)
- Partner nations
- FranceUnited StatesSwitzerland
In The Last Decade
Audrey Thomas‐Schoemann
51 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 93
- Oncology 550
- Hematology 127
- Internal Medicine 41
- Genetics 95
- Pulmonary and Respiratory Medicine 280
Countries citing papers authored by Audrey Thomas‐Schoemann
This map shows the geographic impact of Audrey Thomas‐Schoemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Audrey Thomas‐Schoemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Audrey Thomas‐Schoemann more than expected).
Fields of papers citing papers by Audrey Thomas‐Schoemann
This network shows the impact of papers produced by Audrey Thomas‐Schoemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Audrey Thomas‐Schoemann. The network helps show where Audrey Thomas‐Schoemann may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Audrey Thomas‐Schoemann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 0 | |
| 2 | 2023 | 3 | |
| 3 | 2022 | 6 | |
| 4 | 2021 | 4 | |
| 5 | 2020 | 33 | |
| 6 | 2019 | 33 | |
| 7 | 2019 | 6 | |
| 8 | 2018 | 54 | |
| 9 | 2018 | 43 | |
| 10 | 2017 | 37 | |
| 11 | 2017 | 16 | |
| 12 | 2017 | 15 | |
| 13 | 2016 | 4 | |
| 14 | 2016 | 5 | |
| 15 | 2015 | 7 | |
| 16 | 2015 | 18 | |
| 17 | 2013 | 7 | |
| 18 | 2013 | 9 | |
| 19 | 2012 | 85 | |
| 20 | 2011 | 33 |
About Audrey Thomas‐Schoemann
Audrey Thomas‐Schoemann is a scholar working on Oncology, Geriatrics and Gerontology and Pulmonary and Respiratory Medicine, having authored 54 papers that have together received 1.1k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (11 papers), Renal cell carcinoma treatment (10 papers), Cancer Treatment and Pharmacology (10 papers), Cancer Immunotherapy and Biomarkers (8 papers), HER2/EGFR in Cancer Research (7 papers), Melanoma and MAPK Pathways (6 papers), Lung Cancer Treatments and Mutations (6 papers) and Cancer Genomics and Diagnostics (5 papers). The work is most often cited by research in Oncology (550 citations), Hematology (127 citations) and Internal Medicine (41 citations). Audrey Thomas‐Schoemann has collaborated with scholars based in France, United States and Switzerland. Frequent co-authors include François Goldwasser, Benoı̂t Blanchet, Michel Vidal, Pascaline Boudou‐Rouquette, Jérôme Alexandre, Gaëlle Noé, Audrey Bellesœur, Jennifer Arrondeau, Olivier Huillard and Romain Coriat. Their work appears in journals such as Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, Annals of Oncology, Cancers and Targeted Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.